Clinicopathological significance of hypoxia-inducible factor-1α expression in human pancreatic carcinoma

Histopathology

Volumn 43, Issue 6, 2003, Pages 550-555

  Kitada, T ^a   Seki, S ^a   Sakaguchi, H ^a   Sawada, T ^a   Hirakawa, K ^a   Wakasa, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypoxia inducible factor 1 ; Immunohistochemistry; Pancreatic carcinoma

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE ACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA, PAPILLARY; ANTIGENS, CD34; APOPTOSIS; BLOOD VESSELS; CARCINOMA, ACINAR CELL; CARCINOMA, PANCREATIC DUCTAL; CELL DIVISION; CYSTADENOCARCINOMA, MUCINOUS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; SINGLE-BLIND METHOD; TRANSCRIPTION FACTORS;

EID: 0347478156     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2003.01733.x     Document Type: Article

References (34)

1. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem. Sci. 1999: 24; 68-72.
2. Maxwell PH, Wiesener MS, Chang G et al. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999: 399; 271-275.
3. Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1aα in common human cancers and their metastases. Cancer Res. 1999: 59; 5830-5835.
4. 2 tension. Proc. Natl Acad. Sci. USA 1995: 92; 5510-5514.
5. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995: 70; 1230-1237.
6. 2 homeostasis by hypoxia-inducible factor 1aα. Genes Dev. 1998: 12; 149-162.
7. 2 tension. Am. J. Physiol. 1996: 271; C1172-C1180.
8. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 1999: 15; 551-578.
9. Semenza GL, Jiang BH, Leung SW et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 1996: 271; 32529-32537.
10. Tazuke SI, Mazure NM, Sugawara J et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in Hep G2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl Acad. Sci. USA 1998: 95; 10188-10193.
11. Feldser D, Agani F, Lyer NV et al. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res. 1999: 59; 3915-3918.
12. Kerbel RS, New targets, drugs, and approaches for the treatment of cancer: an overview. Cancer Metastasis Rev. 1998: 17; 145-147.
13. Talks KL, Turley H, Gatter KC et al. The expression and distribution of the hypoxia-inducible factors HIF-1aα and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 2000: 157; 411-421.
14. Zagzag D, Zhong H, Scalzitti JM et al. Expression of hypoxia-inducible factor 1α in brain tumors. Association with angiogenesis, invasion, and progression. Cancer 2000: 88; 2606-2618.
15. Landis SH, Murray T, Bolden S et al. Cancer statistics. 1998. CA Cancer J. Clin. 1998: 48; 6-29.
16. Akakura N, Kobayashi M, Horiuchi I et al. Constitutive expression of hypoxia-inducible factor-1α renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 2001; 61; 6548-6554.
17. Sobin LH, Wittekind C. TNM classification of malignant tumors, 5th edn. New York: Wiley-Liss, Inc., 1997.
18. Weidner N. Current pathologic methods for measuring intra-tumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 1995: 36; 169-180.
19. Reske SN, Grillenberger KG, Glatting G et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J. Nucl. Med. 1997: 38; 1344-1348.
20. Itakura J, Ishikawa T, Freiss H et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin. Cancer Res. 1997: 3; 1309-1316.
21. von-Marshall Z, Cramer T. Hocker M et al. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology 2000: 119; 1358-1372.
22. Baker CH, Solorzano CC, Fidler IJ. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res. 2002: 62; 1996-2003.
23. Carmeliet P, Neeman M, Bono F et al. Role of HIF-1aα in hypoxia mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998: 394; 485-490.
24. An WG, Kanekal M, Simon MC et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 1998: 392; 405-408.
25. Ruggeri B, Zhang SY, Caamano J et al. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor suppressor genes. Oncogene 1992: 7; 1503-1511.
26. Simon B, Weinel R, Hohne M et al. Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. Gastroenterology 1994: 106; 1645-1651.
27. Birner P, Schindl M, Obermair A et al. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000: 60; 4693-4696.
28. Birner P, Schidl M, Obermair A et al. Expression of hypoxia-inducible factor 1α in epithelial ovarian tumors: Its impact on prognosis and on response to chemotherapy. Clin. Cancer Res. 2001; 7; 1661-1668.
29. Aebersold DM, Burri P, Beer KT et al. Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 2001; 61; 2911-2916.
30. Birner P, Gatterbauer B, Oberhuber G et al. Expression of hypoxia-inducible factor-1α in oligodendrogliomas. Its impact on prognosis and on neoangiogenesis. Cancer 2001: 92; 165-171.
31. Lundin J, Nordling S, von-Boguslawsky K et al. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res. 1995: 16; 2659-2668.
32. Karademir S, Sokmen S, Terzi C et al. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J. Hepatobiliary Pancreat. Surg. 2000: 7; 489-495.
33. Bottger TC, Storkel S, Wellek S et al. Factors influencing survival after resection of pancreatic cancer. A DNA analysis and histomorphologic study. Cancer 1994: 73; 63-73.
34. Giulianotti PC, Boggi U, Fornaciari G et al. Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Kloppel vs TNM grading. Int. J. Pancreatol. 1995: 17; 279-289.